MedPath

Ocuterra Therapeutics, Inc.

Ocuterra Therapeutics, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2011-01-01
Employees
11
Market Cap
-
Website
http://ocuterratx.com

Clinical Trials

3

Active:0
Completed:3

Trial Phases

2 Phases

Phase 1:2
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 2
1 (33.3%)

Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

Phase 2
Completed
Conditions
Diabetic Retinopathy
Interventions
Drug: Vehicle control
First Posted Date
2022-06-08
Last Posted Date
2024-08-09
Lead Sponsor
OcuTerra Therapeutics, Inc.
Target Recruit Count
225
Registration Number
NCT05409235
Locations
🇺🇸

Clinical Site 123, Peoria, Arizona, United States

🇺🇸

Clinical Site 150, Phoenix, Arizona, United States

🇺🇸

Clinical Site 111, Beverly Hills, California, United States

and more 65 locations

Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)

Phase 1
Completed
Conditions
Diabetic Macular Edema
Interventions
Drug: SF0166 Topical Ophthalmic Solution
First Posted Date
2016-09-26
Last Posted Date
2023-05-11
Lead Sponsor
OcuTerra Therapeutics, Inc.
Target Recruit Count
44
Registration Number
NCT02914613
Locations
🇺🇸

Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States

🇺🇸

United Medical Research Institute, Inglewood, California, United States

🇺🇸

Martel Eye Medical Group, Rancho Cordova, California, United States

and more 3 locations

Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)

Phase 1
Completed
Conditions
Age-Related Macular Degeneration
Interventions
Drug: SF0166 Topical Ophthalmic Solution
First Posted Date
2016-09-26
Last Posted Date
2023-06-07
Lead Sponsor
OcuTerra Therapeutics, Inc.
Target Recruit Count
44
Registration Number
NCT02914639
Locations
🇺🇸

Retinal Research Institute LLC, Phoenix, Arizona, United States

🇺🇸

Retina Consultants of Orange County, Fullerton, California, United States

🇺🇸

Northern California Retina Vitreous Associates Medical Group, Inc, Mountain View, California, United States

and more 9 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.